---
title: "Oncolytics Biotech Inc - Initiates Phase 2 Study For Metastatic Colorectal Cancer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277481505.md"
datetime: "2026-03-02T14:18:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277481505.md)
  - [en](https://longbridge.com/en/news/277481505.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277481505.md)
---

# Oncolytics Biotech Inc - Initiates Phase 2 Study For Metastatic Colorectal Cancer

March 2 (Reuters) - Oncolytics Biotech Inc (ONCY.O) : \* ONCOLYTICS BIOTECH INC - INITIATES PHASE 2 STUDY FOR METASTATIC COLORECTAL CANCER Source text: Further company coverage: (ONCY.O)

### Related Stocks

- [ONCY.US](https://longbridge.com/en/quote/ONCY.US.md)

## Related News & Research

- [What is Zacks Research's Forecast for ONCY FY2026 Earnings?](https://longbridge.com/en/news/282030787.md)
- [Oncolytics Biotech Completes Domestication to Nevada with New Governance](https://longbridge.com/en/news/281401031.md)
- [How This Biotech Stock Skirted Today's Selloff](https://longbridge.com/en/news/282561025.md)
- [Is Viking Therapeutics (VKTX) Now Pricing In The Biotech Hype Around Its Pipeline?](https://longbridge.com/en/news/282326721.md)
- [Virtue® Labs Expands Retail Footprint to Nearly 600 Ulta Beauty Locations, Fueled by Strong Guest Demand](https://longbridge.com/en/news/282206186.md)